230 related articles for article (PubMed ID: 277222)
1. Enhancement of local tumour control by misonidazole and hyperthermia.
Stone HB
Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
[TBL] [Abstract][Full Text] [Related]
2. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
[No Abstract] [Full Text] [Related]
3. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
Goldfeder A; Brown DM; Berger A
Cancer Res; 1979 Aug; 39(8):2966-70. PubMed ID: 455281
[TBL] [Abstract][Full Text] [Related]
5. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
6. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
Overgaard J
Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
Yamashita M
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
[No Abstract] [Full Text] [Related]
8. Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
Banerjee R; Goldfeder A; Mitra J
Cancer Res; 1983 May; 43(5):2210-5. PubMed ID: 6831443
[TBL] [Abstract][Full Text] [Related]
9. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
10. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
11. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
12. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
Sutherland R; Macfarlane W
Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
Bleehen NM; Honess DJ; Morgan JE
Br J Cancer; 1977 Mar; 35(3):299-306. PubMed ID: 856237
[TBL] [Abstract][Full Text] [Related]
15. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
Davies RW; Hall WS
Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
[TBL] [Abstract][Full Text] [Related]
16. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
Lehman CM; Stewart JR
Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
[TBL] [Abstract][Full Text] [Related]
17. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
[No Abstract] [Full Text] [Related]
18. Selective enhancement of the cytotoxicity of the bleomycin derivative, peplomycin, by local anesthetics alone and combined with hyperthermia.
Mizuno S; Ishida A
Cancer Res; 1982 Nov; 42(11):4726-9. PubMed ID: 6181868
[TBL] [Abstract][Full Text] [Related]
19. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
Horsman MR; Chaplin DJ; Hill SA; Arnold S; Collingridge D; Radacic M; Wood PJ; Overgaard J
Br J Cancer Suppl; 1996 Jul; 27():S168-71. PubMed ID: 8763873
[TBL] [Abstract][Full Text] [Related]
20. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
